Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 379 | 379 | 379 | 1,193 | 305 |
| Gross Profit | 379 | 379 | 379 | 1,193 | 305 |
| Operating Expenses | 18,220 | 19,330 | 20,130 | 20,682 | 15,751 |
| Operating Income | -17,841 | -18,951 | -19,751 | -19,489 | -15,446 |
| Other Income | 503 | 563 | 353 | 385 | 358 |
| Pre-tax Income | -17,338 | -18,388 | -19,398 | -19,104 | -15,088 |
| Net Income Continuous | -17,338 | -18,388 | -19,398 | -19,104 | -15,088 |
| Net Income | $-17,338 | $-18,388 | $-19,398 | $-19,104 | $-15,088 |
| EPS Basic Total Ops | -0.68 | -0.74 | -0.79 | -0.81 | -0.68 |
| EPS Basic Continuous Ops | -0.68 | -0.74 | -0.79 | -0.81 | -0.68 |
| EPS Diluted Total Ops | -0.68 | -0.74 | -0.79 | -0.81 | -0.68 |
| EPS Diluted Continuous Ops | -0.68 | -0.74 | -0.79 | -0.81 | -0.68 |
| EBITDA(a) | $-17,986 | $-19,026 | $-19,813 | $-19,423 | $-15,292 |